SymBio Pharmaceuticals Limited (4582.T)

JPY 212.0

(-1.85%)

Total Debt Summary of SymBio Pharmaceuticals Limited

  • SymBio Pharmaceuticals Limited's latest annual total debt in 2023 was - JPY , down 0.0% from previous year.
  • SymBio Pharmaceuticals Limited's latest quarterly total debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • SymBio Pharmaceuticals Limited reported annual total debt of - JPY in 2022, down 0.0% from previous year.
  • SymBio Pharmaceuticals Limited reported annual total debt of - JPY in 2021, down 0.0% from previous year.
  • SymBio Pharmaceuticals Limited reported quarterly total debt of - JPY for 2024 Q1, down 0.0% from previous quarter.
  • SymBio Pharmaceuticals Limited reported quarterly total debt of - JPY for 2024 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of SymBio Pharmaceuticals Limited (2023 - 2008)

Historical Annual Total Debt of SymBio Pharmaceuticals Limited (2023 - 2008)

Year Total Debt Total Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY -100.0%
2016 450 Million JPY 69993.46%
2015 642 Thousand JPY -51.87%
2014 1.33 Million JPY -33.83%
2013 2.01 Million JPY -25.06%
2012 2.69 Million JPY -21.11%
2011 3.41 Million JPY 0.0%
2010 - JPY 0.0%
2009 - JPY 0.0%
2008 - JPY 0.0%

Peer Total Debt Comparison of SymBio Pharmaceuticals Limited

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY 100.0%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 100.0%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 100.0%
Shionogi & Co., Ltd. 11.62 Billion JPY 100.0%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY 100.0%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY 100.0%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY 100.0%
Eisai Co., Ltd. 206.74 Billion JPY 100.0%
Morishita Jintan Co., Ltd. 425 Million JPY 100.0%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY 100.0%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY 100.0%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY 100.0%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY 100.0%
Tsumura & Co. 79.69 Billion JPY 100.0%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY 100.0%
Torii Pharmaceutical Co., Ltd. 244 Million JPY 100.0%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 100.0%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 100.0%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 100.0%
KYORIN Holdings, Inc. 20.94 Billion JPY 100.0%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY 100.0%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY 100.0%
MedRx Co., Ltd - JPY NaN%
Mizuho Medy Co.,Ltd. - JPY NaN%
Solasia Pharma K.K. 60 Million JPY 100.0%
Modalis Therapeutics Corporation 412.5 Million JPY 100.0%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY 100.0%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 100.0%
Cyfuse Biomedical K.K. 913 Million JPY 100.0%
Toho Holdings Co., Ltd. 30.24 Billion JPY 100.0%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY 100.0%